Amgen Inc. (NASDAQ: AMGN) Rating Reiterated at Jefferies Group

Jefferies Group analysts reiterated its Buy rating on Amgen Inc. (NASDAQ: AMGN) in a note to investors, making it one of the more closely watched stocks on Wall Street. With a rating of Buy on the shares, the company has a 52-week high of $176.64. A number of other analysts have spoken on the company in recent days, and the company has earned a consensus one-year price target of $190.56, higher than the opening price of $172.94. Share prices sometimes get a jump to the upside when analysts reiterate coverage.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Yesterday Amgen Inc. (NASDAQ: AMGN) shares last traded at $173.38, which is an increase of $2.00 from the previous closing price. Opening at $172.94, they varied from $172.46 and $174.26 throughout the day.

Amgen Inc. (NASDAQ: AMGN) currently has a market cap of 129.75B.

2,607,730 shares crossed the trading desk yesterday, 7 percent below the average, out of a total float 747,320,000. Swing traders often use swings in trading volume to identify large volume growth or circulation by institutional investors, so trading volume is likely to increase in the next few days.

However, just a day of significant buy side trading is not enough to determine a trend. As such, market traders will continue to watch for institutional sponsorship as a cue that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors have teams of analysts that research thousands of stocks, so it is good corroboration to see them buying a stock you’re considering.

By following the activity of these professional investors and how they affect moving averages, traders can make the best trades.

Trades for Amgen Inc. (NASDAQ: AMGN) have ranged from $130.09 – 176.64, and the stock now has a 50-day MA of $171.98 and 200-day MA of $159.67. Today’s last price is 0.02% below the 52 week high of $176.64.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors look for companies that have raised their earnings at least 25% or more over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Add a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.